The quarterly expenditure was nearly $30M not $17M (they received $11M from the 2023 R&D expenditure of nearly $30M), $18M spent on R&D last quarter. IMU spent $50M on R&D last financial year and are on track to spend $65M so total of around $45M R&D rebate. A lot of R&D expense, where's our clinical trial updates for VAXINIA and OASIS???
IMU Price at posting:
2.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)